Clinical Events with Edoxaban in South Korean and Taiwanese Atrial Fibrillation Patients in Routine Clinical Practice

Edoxaban is approved for stroke prevention in nonvalvular atrial fibrillation (AF) patients in numerous countries. Outcome data are sparse on edoxaban treatment in AF patients from routine clinical practice, especially in Asian patients. Global ETNA (Edoxaban in rouTine cliNical prActice) is a nonin...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Eue-Keun, Lin, Wei-Shiang, Hwang, Gyo-Seung, Kirchhof, Paulus, De Caterina, Raffaele, Chen, Cathy, Unverdorben, Martin, Wang, Chun-Chieh, Kim, Young-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623093/
https://www.ncbi.nlm.nih.gov/pubmed/34830618
http://dx.doi.org/10.3390/jcm10225337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623093/
https://www.ncbi.nlm.nih.gov/pubmed/34830618
http://dx.doi.org/10.3390/jcm10225337

Ejemplares similares